Various antioxidant therapeutic approaches, i.e. polyethylene glycol-conjugated SOD (PEG-SOD) (160) and polyethylene glycol-conjugated CAT (PEG-CAT) (161), underscore that timely interventions following stroke attenuate neuroinflammatory damage partially due to limiting the ROS generation (162). Here, SOD1 is linked to stroke disorder.